Steven G. DuBois

Dana-Farber/Boston Children's Cancer and Blood Disorders Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 36 papers. Top paper: “Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group”.

Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group

Journal of Clinical Oncology(2023)10.1200/jco.22.01815

N/A

1.7DataRank · unranked

89 citations

Mark Krailo, Julia Glade Bender, Allen Buxton, Nadia N. Laack, R. Lor Randall +20 more

Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3089

N/A

0.609DataRank · unranked

57 citations

Alyaa Al‐Ibraheemi, Duong Doan, Abigail Ward, Catherine Clinton, Juan Putra +11 more

Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.03.006

N/A

0.529DataRank · unranked

33 citations

Arlene Naranjo, Rochelle Bagatell, Steven G. DuBois, Jeannine S. McCune, Sheena C. Tenney +17 more

Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.12.022

N/A

0.416DataRank · unranked

15 citations

Michelle Sanchez, Elinton Lee, Hans J. Hertzler, Nhi M. Luong, Emanuele Mazzola +17 more

Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children’s Oncology Group report

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae103

N/A

0.292DataRank · unranked

6 citations

Ruxu Han, Mark Krailo, David S. Shulman, Brent R. Weil, Christopher B. Weldon +12 more

Factors Associated With Primary Site Local Therapy in Patients With Nonmetastatic Ewing Sarcoma Treated With Interval-Compressed Chemotherapy: A Report From the Children’s Oncology Group

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.11.010

N/A

0.104DataRank · unranked

1 citations

Odion Binitie, Mark Krailo, Daniel J. Indelicato, Alexandra K. Callan, Natalie DelRocco +14 more

A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children’s Oncology Group

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2885

N/A

0.104DataRank · unranked

1 citations

Alexander J. Chou, Allen Buxton, Joel M. Reid, Michael S. Isakoff, Lisa M. Kopp +12 more

A phase II study of larotrectinib for children with newly diagnosed solid tumors and relapsed acute leukemias harboring TRK fusions: Children’s Oncology Group study ADVL1823.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps10560

N/A

0DataRank · unranked

2 citations

Kathleen Ludwig, Donald A. Barkauskas, Steven G. DuBois, Joan Ronan, Erin R. Rudzinski +10 more

Trends in conditional survival and predictors of late death in neuroblastoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10533

N/A

0DataRank · unranked

2 citations

Kevin Campbell, Rochelle Bagatell, Steven G. DuBois, Hannah E. Olsen

Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives

Journal of Clinical Medicine(2021)10.3390/jcm10081685

N/A

0DataRank · unranked

266 citations

James F. Amatruda, Sebastian Bauer, Stéphane Collaud, Enrique de Álava, Steven G. DuBois +13 more

Peripheral Blood Transcript Signatures after Internal 131I-mIBG Therapy in Relapsed and Refractory Neuroblastoma Patients Identifies Early and Late Biomarkers of Internal 131I Exposures

Radiation Research(2021)10.1667/rade-20-00173.1

N/A

0DataRank · unranked

6 citations

Tim Setzkorn, David A. Edmondson, Haley Segelke, Paul F. Wilson, Katherine K. Matthay +6 more

Updated outcomes for patients with completely resected pulmonary recurrent osteosarcoma: A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10023

N/A

0DataRank · unranked

3 citations

Mark Krailo, Ruxu Han, Allen Buxton, Damon R. Reed, Richard Görlick +5 more

Report of the First International Symposium on NUT Carcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0591

N/A

0DataRank · unranked

55 citations

Michael L. Cheng, Glenn J. Hanna, Steven G. DuBois, Nicole G. Chau, Christine L. Hann +18 more

Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

Pediatric Blood & Cancer(2022)10.1002/pbc.29616

N/A

0DataRank · unranked

14 citations

Steven G. DuBois, John Neuhaus, Steve Braunstein, Brent R. Weil, Arlene Naranjo +4 more

Long-term outcomes in patients with localized Ewing sarcoma treated with interval-compressed chemotherapy: A long-term follow-up report from Children’s Oncology Group study AEWS0031.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11505

N/A

0DataRank · unranked

6 citations

Mark Krailo, Allen Buxton, Bruce Pawel, John H. Healey, Odion Binitie +10 more

Clinical and biologic predictors of response to MIBG therapy: A report from the new approaches to neuroblastoma therapy (NANT) consortium.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e22003

N/A

0DataRank · unranked

0 citations

Katherine K. Matthay, Susan Groshen, Yueh‐Yun Chi, Meaghan Granger, Julie R. Park +3 more

Children's Oncology Group's 2023 blueprint for research: Bone tumors

Pediatric Blood & Cancer(2023)10.1002/pbc.30583

N/A

0DataRank · unranked

19 citations

Patrick J. Grohar, Elyssa Rubin, Odion Binitie, Mark Krailo, Jessica L. Davis +3 more

Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131I‐MIBG in patients with relapsed/refractory neuroblastoma

Pediatric Blood & Cancer(2023)10.1002/pbc.30743

N/A

0DataRank · unranked

5 citations

Ajami Gikandi, Bruce Pawel, Daniel Martínez, Meaghan Granger, Araz Marachelian +6 more

SARC037: Results of phase I study of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in relapsed/refractory Ewing sarcoma (ES).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11519

N/A

0DataRank · unranked

14 citations

Karla V. Ballman, Rachel S. Heise, John Glod, Mary Frances Wedekind, Leo Mascarenhas +15 more

Phase 2 study of larotrectinib in children with newly diagnosed infantile fibrosarcoma (IFS): Children’s Oncology Group (COG) ADVL1823 cohort A.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10008

N/A

0DataRank · unranked

5 citations

Kathleen Ludwig, David Hall, Donald A. Barkauskas, Stephan D. Voss, Steven G. DuBois +12 more

Evaluation of local control strategies on patterns of treatment failure in patients with localized ewing sarcoma treated on AEWS1031: A report from the children’s oncology group.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11529

N/A

0DataRank · unranked

2 citations

Odion Binitie, Mark Krailo, Allen Buxton, Daniel J. Indelicato, Alexandra K. Callan +12 more

Evaluation of prevalence and outcomes of serial tyrosine kinase inhibitor use in pediatric patients with advanced solid tumors

Pediatric Blood & Cancer(2023)10.1002/pbc.30652

N/A

0DataRank · unranked

0 citations

Kevin X. Liu, A. Lindsay Frazier, Allison F. O’Neill, Katherine A. Janeway, Steven G. DuBois +2 more

Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children’s Oncology Group Bone Tumor Committee Consensus Statement

Journal of the National Comprehensive Cancer Network(2024)10.6004/jnccn.2024.7063

N/A

0DataRank · unranked

9 citations

Alyaa Al‐Ibraheemi, Jessica L. Davis, C. Matthew Hawkins, Brian T. Craig, Roshni Dasgupta +26 more

Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and field

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110384

N/A

0DataRank · unranked

4 citations

S. Shaaban, Jie Jane Chen, Rochelle Bagatell, Benjamin Lerman, Paul J. Catalano +20 more

SARC037: Phase II results of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in patients (pts) with relapsed/refractory Ewing sarcoma (ES).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.11508

N/A

0DataRank · unranked

13 citations

Karla V. Ballman, Rachel S. Heise, Leo Mascarenhas, John Glod, Mary Frances Frances Wedekind +14 more

Impact of an objective scoring system on initiation of therapy in patients with International Neuroblastoma Risk Group Staging System (INRGSS) stage MS neuroblastoma: A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.10003

N/A

0DataRank · unranked

1 citations

Navin Pinto, Arlene Naranjo, Jed G. Nuchtern, Edward F. Attiyeh, Rochelle Bagatell +12 more

Preoperative Radiotherapy in Patients With Localized Ewing Sarcoma Enrolled on AEWS1031: A Report From the Children's Oncology Group

Pediatric Blood & Cancer(2025)10.1002/pbc.31820

N/A

0DataRank · unranked

5 citations

Alexandra K. Callan, Safia K. Ahmed, Mark Krailo, Natalie DelRocco, Allen Buxton +14 more

Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma

Current Oncology(2025)10.3390/curroncol32030124

N/A

0DataRank · unranked

1 citations

Karen J. Marcus, Steven G. DuBois, Paul J. Catalano, Suzanne Shusterman, Myrsini Ioakeim‐Ioannidou +6 more

Opportunities and Challenges in Drug Development for Pediatric Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0779

N/A

0DataRank · unranked

73 citations

Steven G. DuBois, Julia Glade Bender, Margaret E. Macy, Lucas Moreno, Theodore W. Laetsch

Induction Regimens in High‐Risk Neuroblastoma: Systematic Review of Response Rates and Toxicities

Cancer Medicine(2025)10.1002/cam4.71312

N/A

0DataRank · unranked

0 citations

Eva C. Robinson, Edie Weller, Rochelle Bagatell, Lucas Moreno, Steven G. DuBois +1 more

Trends in conditional survival and predictors of late death in neuroblastoma

Pediatric Blood & Cancer(2020)10.1002/pbc.28329

N/A

0DataRank · unranked

9 citations

Kevin Campbell, Rochelle Bagatell, Steven G. DuBois, Hannah E. Olsen

The Evolving Diagnostic and Treatment Landscape of NTRK-Fusion-Driven Pediatric Cancers

Pediatric Drugs(2020)10.1007/s40272-020-00380-9

N/A

0DataRank · unranked

29 citations

Steven G. DuBois, David S. Shulman

Association of heterogeneous MYCN amplification with clinical features, biological characteristics and outcomes in neuroblastoma: A report from the Children's Oncology Group

European Journal of Cancer(2020)10.1016/j.ejca.2020.04.007

N/A

0DataRank · unranked

31 citations

Arlene Naranjo, Emily Hibbitts, Julie M. Gastier‐Foster, Rochelle Bagatell, Meredith S. Irwin +5 more

Phase I trial of pazopanib in combination with irinotecan and temozolomide (PAZIT) for children and young adults with advanced sarcoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10526

N/A

0DataRank · unranked

9 citations

Jennifer Michlitsch, Avanthi Tayi Shah, Joel M. Reid, Sarah A. Burhow, Eloise M. Graham +7 more

Randomized phase II trial of MIBG versus MIBG/vincristine/irinotecan versus MIBG/vorinostat for relapsed/refractory neuroblastoma: A report from the New Approaches to Neuroblastoma Therapy Consortium.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10500

N/A

0DataRank · unranked

4 citations

Meaghan Granger, Susan Groshen, Denice Tsao‐Wei, Anasheh Shamirian, Scarlett Czarnecki +15 more

Maximum tumor dimension and tumor volume as prognostic factors in patients with newly diagnosed localized Ewing sarcoma (ES)- a report from the Children’s Oncology Group (COG).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11529

N/A

0DataRank · unranked

4 citations

Allen Buxton, Steven G. DuBois, Dian Wang, Nadia N. Laack, Kenneth L. Brown +15 more